Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis
Enrolling By Invitation
18 years - 70 years
All
Phase
2
1 Location
Brief description of study
The main purpose of this study is to see if an experimental drug, TRADIPITANT can help people with diabetic or idiopathic gastroparesis who are suffering from nausea.
Detailed description of study
Who is eligible?
• Patients with idiopathic or diabetic gastroparesis with moderate to severe nausea
• Patients must have had nausea symptoms for at least 6 months
If you participate in the study you will receive the following:
Physical examinations, laboratory tests, study related medications. All procedures and medication are provided at no charge to you.
How long will I be in the study?
The total time in the study could be up to approximately 9 weeks.
Will I be paid to be in the study?
Patients will be compensated for time and travel.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Nausea,Vomiting,Gastroparesis
-
Age: 18 years - 70 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 829015
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
